Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Pharmacoeconomics - Open|March 25, 2020
Brentuximab Vedotin for Treating Relapsed or Refractory CD30-Positive Cutaneous T-Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology AppraisalAngela Stainthorpe, Nigel Fleeman, Rachel Houten, et al.
Pharmacoeconomics|October 12, 2013
Vemurafenib for the treatment of locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma: a NICE single technology appraisalSophie Beale, Rumona Dickson, Adrian Bagust, et al.
BMC Cancer|December 14, 2019
A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodineNigel Fleeman, Rachel Houten, Marty Chaplin, et al.
Pharmacoeconomics|May 15, 2010
Cetuximab for recurrent and/or metastatic squamous cell carcinoma of the head and neck: a NICE single technology appraisalAdrian Bagust, Janette Greenhalgh, Angela Boland, et al.
Pharmacoeconomics - Open|February 12, 2019
Eribulin for Treating Locally Advanced or Metastatic Breast Cancer After One Chemotherapy Regimen: An Evidence Review Group Perspective of a NICE Single Technology AppraisalNigel Fleeman, Adrian Bagust, Rui Duarte, et al.
Pharmacoeconomics - Open|June 27, 2019
Cenegermin for Treating Neurotrophic Keratitis: An Evidence Review Group Perspective of a NICE Single Technology AppraisalNigel Fleeman, James Mahon, Sarah Nevitt, et al.
Health Technology Assessment (Winchester, England)|June 27, 2014
Allopurinol for the treatment of chronic kidney disease: a systematic reviewNigel Fleeman, Gerlinde Pilkington, Yenal Dundar, et al.
Health Technology Assessment (Winchester, England)|June 2, 2021
Modelling tool to support decision-making in the NHS Health Check programme: workshops, systematic review and co-production with usersMartin O'Flaherty, Ffion Lloyd-Williams, Simon Capewell, et al.
International Journal of Technology Assessment in Health Care|November 15, 2014
Economic evaluation of nebulized magnesium sulphate in acute severe asthma in childrenStavros Petrou, Angela Boland, Kamran Khan, et al.
Pharmacoeconomics|September 13, 2014
Eribulin for the treatment of advanced or metastatic breast cancer: a NICE single technology appraisalJanette Greenhalgh, Adrian Bagust, Angela Boland, et al.
Pageof 6